- Home
- YAAS vs INMB Comparison
YAAS vs INMB Comparison
Compare YAAS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YAAS
- INMB
- Stock Information
- Founded
- YAAS 2018
- INMB 2015
- Country
- YAAS China
- INMB United States
- Employees
- YAAS N/A
- INMB N/A
- Industry
- YAAS Computer Software: Prepackaged Software
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- YAAS Technology
- INMB Health Care
- Exchange
- YAAS Nasdaq
- INMB Nasdaq
- Market Cap
- YAAS 59.0M
- INMB 68.9M
- IPO Year
- YAAS 2024
- INMB 2019
- Fundamental
- Price
- YAAS $0.42
- INMB $2.31
- Analyst Decision
- YAAS
- INMB Buy
- Analyst Count
- YAAS 0
- INMB 4
- Target Price
- YAAS N/A
- INMB $9.53
- AVG Volume (30 Days)
- YAAS 4.4M
- INMB 6.9M
- Earning Date
- YAAS 08-15-2025
- INMB 07-31-2025
- Dividend Yield
- YAAS N/A
- INMB N/A
- EPS Growth
- YAAS N/A
- INMB N/A
- EPS
- YAAS N/A
- INMB N/A
- Revenue
- YAAS $521,240.00
- INMB $50,000.00
- Revenue This Year
- YAAS N/A
- INMB $82.14
- Revenue Next Year
- YAAS N/A
- INMB $28,750.98
- P/E Ratio
- YAAS N/A
- INMB N/A
- Revenue Growth
- YAAS N/A
- INMB N/A
- 52 Week Low
- YAAS $0.38
- INMB $1.89
- 52 Week High
- YAAS $7.00
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- YAAS N/A
- INMB 26.84
- Support Level
- YAAS N/A
- INMB $2.22
- Resistance Level
- YAAS N/A
- INMB $2.49
- Average True Range (ATR)
- YAAS 0.00
- INMB 0.94
- MACD
- YAAS 0.00
- INMB -0.24
- Stochastic Oscillator
- YAAS 0.00
- INMB 4.31
About YAAS Youxin Technology Ltd Class A Ordinary shares
Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.